Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 3
2004 4
2005 6
2006 9
2007 6
2008 8
2009 13
2010 5
2011 8
2012 7
2013 6
2014 8
2015 6
2016 7
2017 9
2018 10
2019 6
2020 15
2021 9
2022 8
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

140 results

Results by year

Filters applied: . Clear all
Page 1
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis.
Sands BE, Sandborn WJ, Panaccione R, O'Brien CD, Zhang H, Johanns J, Adedokun OJ, Li K, Peyrin-Biroulet L, Van Assche G, Danese S, Targan S, Abreu MT, Hisamatsu T, Szapary P, Marano C; UNIFI Study Group. Sands BE, et al. N Engl J Med. 2019 Sep 26;381(13):1201-1214. doi: 10.1056/NEJMoa1900750. N Engl J Med. 2019. PMID: 31553833 Free article. Clinical Trial.
AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.
Matsuoka K, Watanabe M, Ohmori T, Nakajima K, Ishida T, Ishiguro Y, Kanke K, Kobayashi K, Hirai F, Watanabe K, Mizusawa H, Kishida S, Miura Y, Ohta A, Kajioka T, Hibi T; AJM300 Study Group. Matsuoka K, et al. Lancet Gastroenterol Hepatol. 2022 Jul;7(7):648-657. doi: 10.1016/S2468-1253(22)00022-X. Epub 2022 Mar 30. Lancet Gastroenterol Hepatol. 2022. PMID: 35366419 Clinical Trial.
Real-world efficacy and safety of advanced therapies in hospitalized patients with ulcerative colitis.
Naganuma M, Kobayashi T, Kunisaki R, Matsuoka K, Yamamoto S, Kawamoto A, Saito D, Nanki K, Narimatsu K, Shiga H, Esaki M, Yoshioka S, Kato S, Saruta M, Tanaka S, Yasutomi E, Yokoyama K, Moriya K, Tsuzuki Y, Ooi M, Fujiya M, Nakazawa A, Abe T, Hisamatsu T; Japanese UC Study Group. Naganuma M, et al. J Gastroenterol. 2023 Dec;58(12):1198-1210. doi: 10.1007/s00535-023-02048-w. Epub 2023 Oct 13. J Gastroenterol. 2023. PMID: 37831183
Adult T-cell Leukemia/Lymphoma with Gastrointestinal Involvement.
Tsuruta K, Takedatsu H, Mihara Y, Mitsuyama K. Tsuruta K, et al. Among authors: mitsuyama k. Intern Med. 2021 Jul 1;60(13):2151-2152. doi: 10.2169/internalmedicine.6583-20. Epub 2021 Feb 8. Intern Med. 2021. PMID: 33551411 Free PMC article. No abstract available.
Antibody markers in the diagnosis of inflammatory bowel disease.
Mitsuyama K, Niwa M, Takedatsu H, Yamasaki H, Kuwaki K, Yoshioka S, Yamauchi R, Fukunaga S, Torimura T. Mitsuyama K, et al. World J Gastroenterol. 2016 Jan 21;22(3):1304-10. doi: 10.3748/wjg.v22.i3.1304. World J Gastroenterol. 2016. PMID: 26811667 Free PMC article. Review.
Interleukin-6 trans-signaling in inflammatory bowel disease.
Mitsuyama K, Sata M, Rose-John S. Mitsuyama K, et al. Cytokine Growth Factor Rev. 2006 Dec;17(6):451-61. doi: 10.1016/j.cytogfr.2006.09.003. Epub 2006 Oct 12. Cytokine Growth Factor Rev. 2006. PMID: 17045835 Review.
Serum leucine-rich alpha-2 glycoprotein and calprotectin in children with inflammatory bowel disease: A multicenter study in Japan.
Yasuda R, Arai K, Kudo T, Nambu R, Aomatsu T, Abe N, Kakiuchi T, Hashimoto K, Sogo T, Takahashi M, Etani Y, Kato K, Yamashita Y, Mitsuyama K, Mizuochi T. Yasuda R, et al. Among authors: mitsuyama k. J Gastroenterol Hepatol. 2023 Jul;38(7):1131-1139. doi: 10.1111/jgh.16166. Epub 2023 Mar 16. J Gastroenterol Hepatol. 2023. PMID: 36880154
Antibodies to Crohn's disease peptide 353 as a diagnostic marker for pediatric Crohn's disease: a prospective multicenter study in Japan.
Mizuochi T, Arai K, Kudo T, Nambu R, Tajiri H, Aomatsu T, Abe N, Kakiuchi T, Hashimoto K, Sogo T, Takahashi M, Etani Y, Takaki Y, Konishi KI, Ishihara J, Obara H, Kakuma T, Kurei S, Yamashita Y, Mitsuyama K. Mizuochi T, et al. Among authors: mitsuyama k. J Gastroenterol. 2020 May;55(5):515-522. doi: 10.1007/s00535-019-01661-y. Epub 2020 Jan 24. J Gastroenterol. 2020. PMID: 31980893
140 results